These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21695550)

  • 1. HLA class I allele promiscuity revisited.
    Rao X; Hoof I; Costa AI; van Baarle D; Keşmir C
    Immunogenetics; 2011 Nov; 63(11):691-701. PubMed ID: 21695550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
    Mitić NS; Pavlović MD; Jandrlić DR
    J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAsupE: an integrated database of HLA supertype-specific epitopes to aid in the development of vaccines with broad coverage of the human population.
    Wang S; Guo L; Liu D; Liu W; Wu Y
    BMC Immunol; 2016 Jun; 17(1):17. PubMed ID: 27307005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I supertypes: a revised and updated classification.
    Sidney J; Peters B; Frahm N; Brander C; Sette A
    BMC Immunol; 2008 Jan; 9():1. PubMed ID: 18211710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive HLA class I allele promiscuity among viral CTL epitopes.
    Frahm N; Yusim K; Suscovich TJ; Adams S; Sidney J; Hraber P; Hewitt HS; Linde CH; Kavanagh DG; Woodberry T; Henry LM; Faircloth K; Listgarten J; Kadie C; Jojic N; Sango K; Brown NV; Pae E; Zaman MT; Bihl F; Khatri A; John M; Mallal S; Marincola FM; Walker BD; Sette A; Heckerman D; Korber BT; Brander C
    Eur J Immunol; 2007 Sep; 37(9):2419-33. PubMed ID: 17705138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules.
    Jain S; Baranwal M
    J Theor Biol; 2019 Mar; 465():34-44. PubMed ID: 30639295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.
    Lasso P; Beltrán L; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Puerta CJ
    PLoS One; 2016; 11(3):e0150996. PubMed ID: 26974162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the prediction of HLA class I-binding peptides using a supertype-based method.
    Wang S; Bai Z; Han J; Tian Y; Shang X; Wang L; Li J; Wu Y
    J Immunol Methods; 2014 Mar; 405():109-20. PubMed ID: 24508661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.
    Prabdial-Sing N; Puren AJ; Bowyer SM
    BMC Immunol; 2012 Dec; 13():67. PubMed ID: 23227878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population response analysis approach to assign class II HLA-epitope restrictions.
    Paul S; Dillon MBC; Arlehamn CSL; Huang H; Davis MM; McKinney DM; Scriba TJ; Sidney J; Peters B; Sette A
    J Immunol; 2015 Jun; 194(12):6164-6176. PubMed ID: 25948811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype.
    Hillen N; Mester G; Lemmel C; Weinzierl AO; Müller M; Wernet D; Hennenlotter J; Stenzl A; Rammensee HG; Stevanović S
    Eur J Immunol; 2008 Nov; 38(11):2993-3003. PubMed ID: 18991276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.
    Sidney J; Grey HM; Southwood S; Celis E; Wentworth PA; del Guercio MF; Kubo RT; Chesnut RW; Sette A
    Hum Immunol; 1996 Feb; 45(2):79-93. PubMed ID: 8882405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.
    Greenbaum J; Sidney J; Chung J; Brander C; Peters B; Sette A
    Immunogenetics; 2011 Jun; 63(6):325-35. PubMed ID: 21305276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent Peptide Presentations of HLA-A
    Zhu S; Liu K; Chai Y; Wu Y; Lu D; Xiao W; Cheng H; Zhao Y; Ding C; Lyu J; Lou Y; Gao GF; Liu WJ
    Front Immunol; 2019; 10():1709. PubMed ID: 31396224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalent T cell epitope promiscuity in ecologically diverse human pathogens.
    Wiens KE; Swaminathan H; Copin R; Lun DS; Ernst JD
    PLoS One; 2013; 8(8):e73124. PubMed ID: 23951341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PopCover-2.0. Improved Selection of Peptide Sets With Optimal HLA and Pathogen Diversity Coverage.
    Nilsson JB; Grifoni A; Tarke A; Sette A; Nielsen M
    Front Immunol; 2021; 12():728936. PubMed ID: 34484239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands.
    Reche PA; Reinherz EL
    Nucleic Acids Res; 2005 Jul; 33(Web Server issue):W138-42. PubMed ID: 15980443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias.
    Doubrovina E; Carpenter T; Pankov D; Selvakumar A; Hasan A; O'Reilly RJ
    Blood; 2012 Aug; 120(8):1633-46. PubMed ID: 22623625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.